Global Veterinary Dermatology Drugs Market to See Robust Growth to 2023, Forecasts PBI in Its Cutting-Edge Report Available at MarketPublishers.com

21 Dec 2017 • by Natalie Aster

LONDON – The world’s market for veterinary dermatology drugs is expected to see growth at a robust pace between 2017 and 2023, spurred by increasing adoption of companion animals, surging food industry, changing lifestyles and social attitudes, robust urbanisation, rising incidence of skin disorders amid animals, enhancing awareness of dermatological disorders, introduction of innovative treatment options, favourable governmental initiative to rise the farm animals production, amidst other growth drivers.

The US is set to hold the dominant position in the world’s dermatology drugs market regarding revenues during 2017-2023; this is primarily attributed to rising pet ownership and well-established veterinary healthcare infrastructure.

The veterinary drug market in Germany is projected to rise at a modest CAGR through to 2023, with demand for veterinary dermatology drugs driven by increasing awareness of animals’ heath.

The adoption of pets is also witnessing an uptake in the developing countries like India, China, Russia, Brazil and Mexico, spurred by certain demographic changes and increasing disposable incomes, etc.

Some of the prominent players active in the world’s veterinary dermatology drugs market comprise Elanco, Zoetis, Merial, Virbac, Bayer Animal Health, IDEXX Laboratories, Ceva Sante Animale, Boehringer Ingelheim Vetmedica and Vetoquinol.

The cutting-edge research report “Veterinary Dermatology Drugs Market , 2012 to 2023” elaborated by Precision Business Insights (PBI) gives a close look at the actual scenario in the world’s market for veterinary dermatology drugs as well as reviews the situation and top trends across the major country-wide markets. Moreover, this study includes reliable market data, traces light on the market dynamics, presents in-depth insights into the market segmentation, discusses the major factors influencing the market development, and also points out and discusses the emerging growth opportunities and challenges of the veterinary dermatology drugs market. in addition, this report covers the competitive scene, offers data on the leading companies and provides a comprehensive future outlook for the veterinary dermatology drugs market up to 2023.

Follow PBI online catalogue at MarketPublishers.com to get access to many other in-demand research reports prepared by this publisher.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com